Skip to main content
OpenTrials
Completed

NCT Number: NCT03608384

Characteristic of Drug Users Chronic Wound

The aim of this study is to describe demographic, clinical, etiological characteristic and evolution of drug addict's chronic wounds .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Wound Drug Use Wounds and Injuries

Sex eligibility

All sexes

Study type

Observational

Primary location

CHRU De Nancy

Vandœuvre-lès-Nancy, 54500, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all drug addict with chronic wound ( evolving at least since 1 month)

Exclusion criteria

  • use following medication inductor of cutaneous ulcer: hydroxycarbamide, gefitinib, cetuximab, sunitinib, sorafenib, pazopanib, gemcitabine, sirolimus, methotrexate, nicorandil .

Treatment and study plan

Primary outcomes

  1. clinical venous insufficiency - presence of oedema

    Time frame: at inclusion

    presence of oedema

Secondary outcomes

  1. clinical venous insufficiency - presence of varicose

    Time frame: at inclusion

    presence of varicose

  2. clinical venous insufficiency - presence of white atrophy

    Time frame: at inclusion

    presence of white atrophy

  3. clinical venous insufficiency - presence of varicose eczema

    Time frame: at inclusion

    presence of varicose eczema

Sponsors and collaborators

Lead sponsor

Central Hospital, Nancy, France

Other

Registry information

Acronym: TOXIPO

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jul 31, 2018
Registry last updated
Apr 12, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.